NHS National Pharmaceuticals Transition 2021_3
The NHS Commissioning Board (operating under the name of NHS England)contractFind a Tender ↗Ref ocds-h6vhtk-02b7a632014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
59
32 SME
Lots
7
59 awarded
Published
04 Nov 2021
Total lots
7
Awarded
7
0 pending
Estimated total
—
Awarded total
—
Lot 1cancelled
Hospital Only Products – CESW region
Award value
—
Start
30 Sept 2021
End
31 May 2024
Estimated
—
CPV
33600000
Awarded to 25 suppliers
Lot 2cancelled
Hospital Only Products – LSNE region
Award value
—
Start
30 Sept 2021
End
30 Jun 2022
Estimated
—
CPV
33600000
Awarded to 9 suppliers
Lot 3cancelled
Hospital Only Products – NWLN region
Award value
—
Start
30 Sept 2021
End
31 Jan 2023
Estimated
—
CPV
33600000
Awarded to 7 suppliers
Lot 4cancelled
Oral (plus non-parenteral) products: All regions
Award value
—
Start
30 Sept 2021
End
30 Sept 2023
Estimated
—
CPV
33600000
Awarded to 6 suppliers
Lot 6cancelled
Transition Products – LSNE region
Award value
—
Start
25 Oct 2021
End
31 Jan 2023
Estimated
—
CPV
33600000
Lot 5cancelled
Transition Products – CESW region
Award value
—
Start
25 Oct 2021
End
30 Jun 2022
Estimated
—
CPV
33600000
Awarded to 6 suppliers
Lot 7cancelled
Transition Products – NWLN region
Award value
—
Start
25 Oct 2021
End
30 Sept 2023
Estimated
—
CPV
33600000
Awarded to 4 suppliers